Aardvark Therapeutics, Inc. Common Stock (AARD) NASDAQ

11.27

+0.14(+1.26%)

Updated at June 03 09:55AM

Currency In NaN

Valuation

Market Cap184.73M
Enterprise Value123.87M
P/E Ratio-6.04
PEG Ratio0.18
Price/Sales Ratio0
Price/Book Ratio0.97
Enterprise/Revenue0
Enterprise/EBITDA-8.01

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin0
Operating Margin0

Management Effectiveness

Return On Assets-0.15
Return On Equity-12.85

Income Statement

Revenue0
Revenue/Share0
Gross Profit0
EBITDA-22.79M
Net Income-20.59M
Diluted EPS-1.59

Balance Sheet

Total Cash151.26M
Total Cash/Share11.46
Total Debt726,000
Total Debt/Equity0
Current Ratio25.86
Book Value Per Share11.42

Price History

52-Week Change-22.22
52-Week High19.58
52-Week Low4.88
Moving Average 50 Days9.29
Moving Average 200 Days10.17

Statistics

Average Volume94,969
Shares Outstanding21.7M
% Held by Institutions65.83

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A